Morus Inc. (CEO: Ryo Sato; Head Office: Chiyoda-ku, Tokyo; hereinafter “Morus”), dedicated to weaving tradition and nurturing a healthy future through the power of nutrition, is pleased to announce our wellness brand KAIKO product has been included in the Health Sciences Authority (HSA) of Singapore’s “List of Notified Complementary Health Products.”
HSA’s Voluntary Notification System allows companies to declare that their products comply with the published safety, quality, and labelling standards for Complementary Health Products, and to have that declaration published for public reference. With KAIKO DNJ+ now included, the product information we declared is publicly viewable on HSA’s official database.
As Morus continues to expand its global footprint, we remain dedicated to bridging traditional Japanese heritage with modern biotechnology. Moving forward, we will leverage this milestone to deliver safe, transparent, and science-backed wellness solutions to consumers across Southeast Asia and beyond.
Please note that this acknowledgement is not to be construed as an endorsement of the product or used for its advertisement or sales promotion. This listing is not a guarantee of efficacy or an endorsement from HSA — it reflects transparency: the information we have declared is on record and publicly available for reference.
info@morus.com
